Tag: TRI

Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

SUZHOU, China, July 25, 2025 /PRNewswire/ -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the...

Avalanche Energy Awarded $10 Million Grant from Washington State to Develop FusionWERX Neutron Factory

Award and 300,000-Volt technological breakthrough position Avalanche to unlock key commercial revenue from fusion devices SEATTLE, July 23, 2025 /PRNewswire/ -- Avalanche Energy, a fusion...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

Evyve Becomes First Customer to Deploy Tritium’s Revolutionary TRI-FLEX Ultra-Scaling Platform to Meet Rapid Network Growth Demands

Partnership combines Evyve's sustainable charging leadership with Tritium's industry-first lifetime

Partnership combines Evyve's sustainable charging leadership with Tritium's industry-first lifetime

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

– Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1 – –...

Thomson Reuters Corp to Join the Nasdaq-100 Index® Beginning July 28, 2025

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Thomson Reuters Corp (Nasdaq: TRI), will become a component of the Nasdaq-100 Index^® (Nasdaq: NDX^®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, July 28, 2025. Thomson Reuters Corp will replace ANSYS, Inc. (Nasdaq: ANSS) in the Nasdaq-100 Index^® and the Nasdaq-100 Equal Weighted™ Index.

Gibbons Pools, Long Island Pool Innovator, Celebrates 50 Years

Marking a half-century milestone in 2025, the family-owned company, led by its third generation, has expanded from residential pools to include wellness amenities and...

Delivering Wi-Fi 7 Without the Price Tag: EnGenius Announces Affordable ECW520 Access Point

EnGenius ECW520: Bridging Enterprise Wi-Fi 7 Power with SMB Affordability COSTA MESA, Calif., July 16, 2025 /PRNewswire/ -- EnGenius Technologies Inc., a global leader in advanced...

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully...

Made Scientific and Sentinel BioTherapeutics Announce Strategic Manufacturing Partnership to Advance Ph I/II Allogeneic ePP Encapsulated Cell Therapy Program

PRINCETON, N.J. and HOUSTON, July 15, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Sentinel...

Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the...

- The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day 29 of a single-dose of...

On Time Trucking Achieves ISO 9001:2015 Certification

New York trucking company completes rigorous assessment and audit of operating processes and procedures, receives certification for quality management systems.Reinforces company's 40 years of...

Jeep® Brand Introduces Two New Special-Edition Wagoneer Models

AUBURN HILLS, Mich., July 11, 2025 /PRNewswire/ -- ...

Tencent Cloud, UXSoft, and BAPE Hong Kong Limited Collaborate to Power Global Retail Infrastructure for A Bathing Ape®

PIS Showcases Global Growth Strategy & Expansion Plan at Posidonia 2026

Age is just a Number. Mobility is a Choice.

Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

Avalanche Energy Awarded $10 Million Grant from Washington State to Develop FusionWERX Neutron Factory

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

Evyve Becomes First Customer to Deploy Tritium’s Revolutionary TRI-FLEX Ultra-Scaling Platform to Meet Rapid Network Growth Demands

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

Thomson Reuters Corp to Join the Nasdaq-100 Index® Beginning July 28, 2025

Gibbons Pools, Long Island Pool Innovator, Celebrates 50 Years

Delivering Wi-Fi 7 Without the Price Tag: EnGenius Announces Affordable ECW520 Access Point

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Made Scientific and Sentinel BioTherapeutics Announce Strategic Manufacturing Partnership to Advance Ph I/II Allogeneic ePP Encapsulated Cell Therapy Program

Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the...

On Time Trucking Achieves ISO 9001:2015 Certification

Jeep® Brand Introduces Two New Special-Edition Wagoneer Models

Explore

Press Releases

News & Opinion

Living

Others

Follow us